CONCERTA Methylphenidate — Percent Change (as a percent)
Products & Services · Percent Change (as a percent)Johnson & Johnson CONCERTA Methylphenidate — Percent Change (as a percent) decreased by 108.0% to -41.6% in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 54.6%, from -91.7% to -41.6%. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2018
Last reportedQ3 2025
How to read this metric
A positive percentage indicates revenue growth and strong market positioning, whereas a negative percentage suggests declining demand, market saturation, or loss of exclusivity.
Detailed definition
This metric measures the period-over-period percentage growth or decline in net sales for the Concerta and methylphenida...
Peer comparison
Comparable to year-over-year or sequential revenue growth rates for specific pharmaceutical products reported by other healthcare companies.
Metric ID:
jnj_segment_concerta_methylphenidate_percent_change_as_a_percentHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -4.9% | 5.8% | -0.8% | 20.5% | -36.1% | 7.5% | 15.7% | 42.8% | 71.7% | -55.4% | -79% | -91.7% | -42.6% | -20% | -41.6% |
| QoQ Change | — | +218.4% | -113.8% | >999% | -276.1% | +120.8% | +109.3% | +172.6% | +67.5% | -177.3% | -42.6% | -16.1% | +53.5% | +53.1% | -108.0% |
| YoY Change | — | — | — | — | -636.7% | +29.3% | >999% | +218.6% | +856.0% | — | -284.6% | -227.9% | +23.1% | +74.7% | +54.6% |
Range-91.7% – 71.7%
CAGR+84.2%
Avg YoY Growth+217.0%
Median YoY Growth+42.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's concerta methylphenidate — percent change (as a percent)?
- Johnson & Johnson (JNJ) reported concerta methylphenidate — percent change (as a percent) of -41.6% in Q3 2025.
- How has Johnson & Johnson's concerta methylphenidate — percent change (as a percent) changed year-over-year?
- Johnson & Johnson's concerta methylphenidate — percent change (as a percent) increased by 54.6% year-over-year, from -91.7% to -41.6%.
- What does concerta methylphenidate — percent change (as a percent) mean?
- The percentage change in revenue for Concerta and methylphenidate products compared to the previous period.